|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/04 |
| (11) | Patento numeris | 2882736 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13753229.7 |
| Europos patento paraiškos padavimo data | 2013-08-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-06-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-01-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/054099 |
| Data | 2013-08-08 |
| (87) | Numeris | WO 2014/025978 |
| Data | 2014-02-13 |
| (30) | Numeris | Data | Šalis |
| 201261681477 P | 2012-08-09 | US |
| (72) |
TRAVERSE, John, F., US
ZHANG, Chengmin, US
FEIGELSON, Gregg, B., US
COHEN, Benjamin, M., US
LEONG, William, W., US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | PROCESSES FOR THE PREPARATION OF (S)-3-4-((4-(MORPHOLINOMETHYL) BENZYL)OXY)-1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE AND PHARMACEUTICALLY ACCEPTABLE FORMS THEREOF |
| PROCESSES FOR THE PREPARATION OF (S)-3-4-((4-(MORPHOLINOMETHYL) BENZYL)OXY)-1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE AND PHARMACEUTICALLY ACCEPTABLE FORMS THEREOF |